Researchers have identified an antioxidant in locally grown black tea leaves as a potential inhibitor of protease activity in SARS-CoV-2, the virus that causes COVID-19, Chiayi Chang Gung Memorial Hospital said on Wednesday.
A research team led by Wu Ching-yuan (吳清源), head of the hospital’s Department of Traditional Chinese Medicine, used a computer program to identify potential antiviral components in traditional plants, the hospital said in a statement.
Theaflavin, a polyphenolic compound, shows broad-spectrum antiviral activity against several viruses and could be used as a lead compound for the development of a SARS-CoV-2 inhibitor to target the DNA-directed ribonucleic acid (RNA) polymerase (RdRp) enzyme.
Photo copied by Lin I-chang, Taipei Times
In coronaviruses, RdRp catalyzes the replication of RNA from a template, making it an attractive candidate to help develop a treatment, Wu said.
RdRp in SARS-CoV-2 is also a primary target for the antiviral remdesivir, which the WHO has called the most promising drug available for the treatment of COVID-19, he said.
Remdesivir works by inhibiting RdRp, which many RNA viruses — including coronaviruses — use to replicate themselves.
The antiviral effects of theaflavin are similar to those of remdesivir, Wu said.
However, the exact in vivo effect is still unclear, and further research is needed to confirm the mechanism whereby theaflavin targets SARS-CoV-2, Wu said.
The findings were published by the American Society for Microbiology in the Journal of Medical Virology on March 13, the hospital said.
In other news, the Central Epidemic Command Center (CECC) on Thursday said that quinoline antimalarial drugs, which have been discussed as a possible treatment for COVID-19, are produced in Taiwan and could be made available if testing proves them to be effective against the novel coronavirus.
In a small French study, doctors used a drug in the quinoline family — hydroxychloroquine — to reduce the duration and severity of COVID-19 symptoms in people with mild cases, said Chang Shan-chwen (張上淳), convener of the center’s expert advisory panel.
If properly tested and approved, a process that normally takes 12 to 18 months, the drug could conceivably reduce the burden on medical resources such as quarantine facilities, Chang said.
Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the CECC, said that there is one manufacturer of quinoline drugs in Taiwan.
If the treatment were proved to be viable, the government’s first priority would be to guarantee domestic supply, Chen said.
The government could participate in the distribution of the drug on the precondition of not harming the manufacturer’s commercial interests, Chen said.
Internationally, drug distribution rights could be used diplomatically to build ties with international partners to address shortages amid the pandemic, he said.
Drugs that have been touted as potentially effective against COVID-19 have become the subject of heated competition in the past few weeks as governments scramble to combat the disease.
Remdesivir is being used on a trial basis in Taiwan and has reduced fevers in the three COVID-19 patients who have been treated with it, although its effect on overall recovery time is still being studied, Chang said.
STATS: Taiwan’s average life expectancy of 80.77 years was lower than that of Japan, Singapore and South Korea, but higher than in China, Malaysia and Indonesia Taiwan’s average life expectancy last year increased to 80.77 years, but was still not back to its pre-COVID-19 pandemic peak of 81.32 years in 2020, the Ministry of the Interior said yesterday. The average life expectancy last year increased the 0.54 years from 2023, the ministry said in a statement. For men and women, the average life expectancy last year was 77.42 years and 84.30 years respectively, up 0.48 years and 0.56 years from the previous year. Taiwan’s average life expectancy peaked at 81.32 years in 2020, as the nation was relatively unaffected by the pandemic that year. The metric
Taiwan High Speed Rail Corp. (THSRC) plans to ease strained capacity during peak hours by introducing new fare rules restricting passengers traveling without reserved seats in 2026, company Chairman Shih Che (史哲) said Wednesday. THSRC needs to tackle its capacity issue because there have been several occasions where passengers holding tickets with reserved seats did not make it onto their train in stations packed with individuals traveling without a reserved seat, Shih told reporters in a joint interview in Taipei. Non-reserved seats allow travelers maximum flexibility, but it has led to issues relating to quality of service and safety concerns, especially during
A magnitude 5.1 earthquake struck Chiayi County at 4:37pm today, the Central Weather Administration (CWA) said. The hypocenter was 36.3km southeast of Chiayi County Hall at a depth of 10.4km, CWA data showed. There were no immediate reports of damage resulting from the quake. The intensity of the quake, which gauges the actual effect of a seismic event, measured 4 in Chiayi County, Tainan and Kaohsiung on Taiwan's seven-tier intensity scale, the data showed. The quake had an intensity of 3 in Chiayi City and Yunlin County, while it was measured as 2 in Pingtung, Taitung, Hualien, Changhua, Nantou and Penghu counties, the data
The Supreme Court today rejected an appeal filed by former Air Force officer Shih Chun-cheng (史濬程), convicted of Chinese Communist Party (CCP) espionage, finalizing his sentence at two years and two months for contravening the National Security Act (國家安全法). His other ruling, a ten-month sentence for an additional contravention, was meanwhile overturned and sent to the Taichung branch of the High Court for retrial, the Supreme Court said today. Prosecutors have been notified as Shih is considered a flight risk. Shih was recruited by Chinese Communist Party (CCP) intelligence officials after his retirement in 2008 and appointed as a supervisor
RSS